Breath Analysis for Evaluation of Radiation Exposure in Lung Cancer Patients Treated With Radiation

This study has been completed.
Information provided by (Responsible Party):
Stanford University Identifier:
First received: August 12, 2010
Last updated: August 20, 2013
Last verified: August 2013
Patients treated with radiation therapy for lung tumors can experience inflammation after treatment. This study hopes to evaluate the use of breath analysis to evaluate changes in the composition of exhaled breath in patients undergoing radiotherapy. If changes can be detected, this may ultimately serve as biomarkers for identifying patients at highest risk for radiation-induced lung injury (radiation pneumonitis).

Condition Intervention
Lung Cancer
Non-Small Cell Lung Cancer
Small Cell Lung Cancer
Procedure: Exhaled Breath Sampling

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Breath Analysis for Evaluation of Radiation Exposure in Lung Cancer Patients Treated With Radiation: A Feasibility Study

Resource links provided by NLM:

Further study details as provided by Stanford University:

Primary Outcome Measures:
  • Pre and post-radiation FeNO (fraction of exhaled nitric oxide) measurements [ Time Frame: Every 3 months for 1 year ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Pre and post-radiation CO (carbon monoxide), CO2 (carbon dioxide), and N2O (nitrous oxide) measurements and feasibility as the fraction of patients unable to give a breath sample. Adverse events are not expected but any that appear related to the breath [ Time Frame: 1 yr ] [ Designated as safety issue: No ]

Enrollment: 20
Study Start Date: August 2010
Study Completion Date: March 2012
Primary Completion Date: September 2011 (Final data collection date for primary outcome measure)
Intervention Details:
    Procedure: Exhaled Breath Sampling
    Standard of care
    Other Name: breath gas analysis

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients with lung tumors who are undergoing radiation therapy

Inclusion Criteria:

  • Diagnosis of any type of lung tumor
  • Medical recommendation (independent of the study) that the patient undergo thoracic radiation therapy. Radiation therapy may be either fractionated or hypofractionated (i.e. radiosurgery)
  • Age >= 18 years old
  • Any gender and any ethnic background will be recruited
  • Capable of giving written informed consent

Exclusion Criteria:

  • Inability of giving written informed consent
  • Pregnancy or breast-feeding
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01182155

United States, California
Stanford University School of Medicine
Stanford, California, United States, 94305
Sponsors and Collaborators
Stanford University
Principal Investigator: Dr. Maximilian Diehn MD/PhD Stanford University
  More Information

Responsible Party: Stanford University Identifier: NCT01182155     History of Changes
Other Study ID Numbers: LUN0043  SU-08102010-6705 
Study First Received: August 12, 2010
Last Updated: August 20, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by Stanford University:
Lung Cancer Non-Small Cell Cancer (NSCLC)
Lung Cancer Small Cell Lung Cancer (SCLC)

Additional relevant MeSH terms:
Carcinoma, Non-Small-Cell Lung
Lung Neoplasms
Small Cell Lung Carcinoma
Bronchial Neoplasms
Carcinoma, Bronchogenic
Lung Diseases
Neoplasms by Site
Respiratory Tract Diseases
Respiratory Tract Neoplasms
Thoracic Neoplasms processed this record on May 25, 2016